Labios Pharmaceuticals Private Limited, a active private limited company, was established on 25 February 2019 in Nashik, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290MH2019PTC321764. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Pranav Eknath Bhosekar (Director), Makarand Suresh Hardikar (Director), Swarupa Bhalchandra Ursekar (Director). Past directors included Ajinkya Babanrao Wagh, Shreyas Nandkishor Padhye. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 3, Aaradhya Regency Apartment, Near Old Ashoka School,, Nashik, Maharashtra, 422003.
U24290MH2019PTC321764
321764
25 February 2019
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Labios Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pranav Eknath Bhosekar | Director | 25 Mar 2019 | Current |
| Makarand Suresh Hardikar | Director | 25 Feb 2019 | Current |
| Swarupa Bhalchandra Ursekar | Director | 25 Feb 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jun 2021 | Past |
| Pramod Abcsdd | Director | 26 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Labios Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.38% increase. The company also saw a substantial fall in profitability, with a 33.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Labios Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Labios Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Labios Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labios Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Labios Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Labios Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Pranav Eknath Bhosekar was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Progress on Makarand Suresh Hardikar was appointed as a Director was appointed as a Director on 25 Feb 2019 & has been associated with this company since 6 years 9 months . was documented.
Swarupa Bhalchandra Ursekar was appointed as a Director was appointed as a Director on 25 Feb 2019 & has been associated with this company since 6 years 9 months . was recorded as a recent event.
Labios Pharmaceuticals Private Limited was registered on 25 Feb 2019 with Roc Mumbai & aged 6 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Labios Pharmaceuticals Private Limited is U24290MH2019PTC321764.
Labios Pharmaceuticals Private Limited is headquartered at Shop No. 3, Aaradhya Regency Apartment, Near Old Ashoka School,, Nashik, Maharashtra, 422003.
Labios Pharmaceuticals Private Limited was incorporated on 25 February 2019.
The current directors of Labios Pharmaceuticals Private Limited are
The primary industry of Labios Pharmaceuticals Private Limited is Chemicals.
Labios Pharmaceuticals Private Limited is unlisted.
The authorized capital of Labios Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX